Tranexamic Acid Use on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty

NARecruitingINTERVENTIONAL

Enrollment

210

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

April 30, 2027

Conditions

Postoperative Bleeding

Interventions

DRUG

Tranexamic acid

This is a 3 arm RCT using the three dosage regimens mentioned above. Placebo doses will be provided for the 0, 8, 16 and 24 hours without TXA

Trial Locations (1)

RECRUITING

St. Mary's Hospital Center, Montreal

All Listed Sponsors

lead

St. Mary's Research Center, Canada

OTHER

NCT06208267 - Tranexamic Acid Use on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter